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httcense.Abstract Background: Tuberculosis (TB) in elderly is a worldwide problem.
Objective: To evaluate differences in clinical, radiological, laboratory features, adverse antitu-
berculosis drug reactions and TB-related mortality in elderly and young pulmonary TB patients.
Results: The study included analysis of the medical history, chest radiographic and laboratory
ﬁndings in 124 elderly and 124 young pulmonary TB patients, with mean age of 60.5 ± 9.1 and
31.6 ± 10.8 years, respectively (p< 0.0001), and comparable male predominance. There were
higher frequencies of dyspnea, anorexia, weight loss, weakness and mental changes in elderly than
young (p= 0.001, 0.004, < 0.0001, < 0.0001, 0.002, respectively) while there were higher frequen-
cies of cough and sputum production, hemoptysis, and fever in young than elderly (p= 0.008, 0.01,
0.04, respectively) patients. Elderly had higher frequency of comorbidities (p< 0.0001). Elderly had
higher frequency of atypical radiological ﬁndings for pulmonary tuberculosis and initial misdiagno-
sis as pneumonia and lung cancer (p< 0.0001, 0.001, 0.01, respectively). Elderly had a higher level
of erythrocytic sedimentation rate (p= .01). Young had a higher frequency of positive sputum
direct smear for acid fast bacilli (p= 0.04). Elderly had a higher role for ﬁberoptic bronchoscope932329242; mobile: +20
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270 M.T. Hussein et al.in diagnosis of pulmonary TB (p= 0.001). There was a delay in the diagnosis of pulmonary TB in
elderly (p< 0.0001) patients. Anti-tuberculosis drug side effects and TB-related mortality were
more frequent in elderly (p< 0.0001, 0.03, respectively)patients.
Conclusion: This study showed that elderly pulmonary TB patients had higher frequencies of
atypically clinical, radiological presentations, co-morbidities, anti-tuberculosis drug adverse reac-
tions and TB related mortality.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Along with the elderly populations’ growth in numbers, there
has been an increase in the number of TB cases among elderly
populations [1]. The loss of cellular immune reactivity (i.e.,
negative tuberculin skin test) to Mycobacterium tuberculosis
occurs in some elderly population who were previously in-
fected with this organism, thereby rendering them vulnerable
to re-infection. Also, the elderly are at a greater risk for reac-
tivation of latent TB. In elderly, approximately three-quarters
of all TB cases occur in the respiratory tract [2,3]. Although,
the mortality rate of TB in elderly is six times higher, TB is
a preventable cause of death in elderly patients [3]. An active
approach to diagnose, treat and prevent TB in the elderly is
indicated [3–6]. Elderly TB patients should remain under
observation until adherence with their treatment regimen [7,8].
Age classiﬁcation varied between countries and over time.
Deﬁnitions fell into three main categories: (1) chronological;
(2) change in capabilities (i.e., invalid status, senility and
change in physical characteristics); and (3) change in social role
(i.e., change in work patterns, adult status of children and
menopause). Most developed world countries have accepted
the chronological age of 60/or 65 as a deﬁnition of elderly per-
son, but like many westernized concepts, this does not adapt
well to the situation in Africa. According to WHO (2011), it
seems more appropriate in Africa to use a combination of
the three deﬁnitions. It was felt that by using age of 50 years,
this project will be indirectly incorporating these other deﬁni-
tions [9].Patients and methods
This study was conducted in Sohag University Hospital during
the period between January 2010 and December 2012. Ethics
committee approved the study. Written informed consents
were obtained from the entire patients. This study included
only patients with active pulmonary TB who were diagnosed
and treated at our hospital. Exclusion criteria were all other
forms of TB, like hilar and/or mediastinal lymphadenopathy,
TB pleural effusion, pulmonary TB with co-existing extra-pul-
monary TB and miliary TB to allow better data comparison,
relapsed or multi-drug resistant cases. According to WHO
(2011), we used age of 50 years as a deﬁnition of elderly [9].
All patients were human immunodeﬁciency virus negative.
Collected data included the following: demographic charac-
teristics, presenting symptoms and body temperature, underly-
ing illnesses, laboratory investigations including (1) complete
blood count (was done by Coulter counter), (2) erythrocytic
sedimentation rate (ESR) by westergreen methods, (3) micro-
biological investigation: specimen: morning sputum or bron-choalveolar lavage samples submitted for diagnosis of
tuberculosis, samples were collected from each patient in
50 ml sterile plastic containers. Decontamination of sputum
samples was carried out using the N-acetyl-L-cysteine
(NALC/NaOH) method. (A) Microscopy: smears were stained
with the ZN technique. (B) Culture: inoculation was done onto
slants of Lowenstein Jensen medium. (4) Liver function tests
were performed on a Boehringer Mannheim (BM)/autoana-
lyzer Cobas Integra 400 (checked before beginning of anti-
TB treatment).
Radiological features were recorded according to interpre-
tation of the initial chest radiography taken when the patient
visited the hospital before a deﬁnite diagnosis had been made.
That included the location and lesion appearance. The radio-
logical appearance of pulmonary TB lesion was classiﬁed as
typical ﬁbrous nodular inﬁltrates and/or a cavitary lesion, con-
solidation, large opacity mimicking a mass or as others. Loca-
tion of TB lesion was categorized as upper lobe involvement
(upper lobe alone or upper with middle or lower lobe) or iso-
lated middle and/or lower lobe involvement. Initial clinical
diagnosis (before deﬁnite diagnosis) was classiﬁed as pulmon-
ary TB, bacterial pneumonia, lung cancer, or others (such as
sarcoidosis, etc).
Fiberoptic bronchoscope, bronchoalveolar lavage (BAL),
brush and/or biopsy were performed only in selected cases
such as patients who cannot expectorate or other diagnosis
was expected such as lung cancer. Active pulmonary TB was
diagnosed in the presence of at least one of the following crite-
ria; (1) a positive sputum or BAL smear and/or positive culture
for AFB regardless of sputum or BAL smear results; (2) biopsy
based histopathological conﬁrmation of the lung lesion; (3)
clinical and chest radiographic ﬁndings that are highly sugges-
tive of TB and a favorable response to anti-TB treatment even
in absence of bacteriologic or histopathological conﬁrmation.
Diagnosis time was calculated from onset of symptoms till ﬁ-
nal diagnosis was obtained
After diagnosis of active pulmonary TB had been made and
anti- TB medications started, patients were seen 1 week after
medications and every 2 weeks thereafter, and at these visits
were questioned about drug side effects. Chest radiograph
and microbiological study were performed monthly. Liver
function tests were carried out 1 week after beginning of med-
ication and monthly thereafter. Patients were treated initially
using the following regimen: isoniazed, rifampicin, ethambutol
and pyrazinamid or streptomycin. Pyrazinamid was not pre-
scribed for patients with liver diseases e.g., liver cirrhosis or ac-
tive hepatitis. Treatment duration was at least 6 months. Anti-
TB drug adverse reactions included mild gastrointestinal dis-
turbances, severe gastrointestinal disturbances, mild transient
liver transaminases [alanine transaminase (ALT) and aspartate
transaminase (AST)] raise, and drug induced hepatitis was de-
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mal upper limit, (2) any elevation of ALT and AST above ba-
sal levels in the presence of ictric hepatitis. If drug induced
hepatitis was suspected, anti-TB drugs were stopped, when li-
ver function tests returned to normal the anti-TB drugs were
sequentially reintroduced. Pyrazinamid was not reintroduced
[10,11]. Mortality during treatment was recorded.
Statistics
Statistical analysis was performed using the SPSS Version 11.0
soft ware package. Statistical differences between the clinical
features of the two groups were determined with chi-square
test. All values are reported as mean ± standard deviation
(SD). A p value (2-tailed) 6 0.05 was considered statistically
signiﬁcant. The student’s t test was used when indicated for
independent means.
Results
According to inclusion and exclusion criteria, the study in-
cluded 124 elderly (P50 year) and 124 young patients
(<50 year) with active pulmonary TB.
Table 1 showed that mean ages of the elderly group and
young group were 60.5 ± 9.1 years and 31.6 ± 10.8 years,
respectively (p< 0.0001). There was a comparable male pre-
dominance in both groups (p= 0.2). Co-morbid diseases were
frequent in elderly patients (p< 0.0001). Diabetes mellitus was
the most frequent co-morbidity in both groups, without statis-
tically signiﬁcant difference. An initial diagnosis of active pul-
monary TB was made correctly in 86.3% (n= 107) of the
young but only in 65.3% (n= 81) of elderly patients
(p< 0.0001). 25% (n= 31) of elderly were misdiagnosed as
bacterial pneumonia compared to 12.1% (n= 15) of young
patients (p= 0.008). 8.9% (n= 11) of elderly but only 1.6%Table 1 Demographic data, co-morbid diseases and ini
young patients.
Elderly (P50 year, %) (n= 1
Age (mean ± SD) 60.5 ± 9.1
(range, year) 50–90
Gender
Male 78 (62.9)
Female 46 (37.1)
Co-morbid diseases
Diabetes mellitus 27 (21.8)
Chronic lung disease 22 (17.7)
Liver disease 16 (12.9)
Cardiovascular diseasea 21 (16.9)
Renal disease 3 (2.4)
Malignancy 1 (0.8)
Total 75 (60.5)
Initial diagnosis
Tuberculosis 81 (65.3)
Pneumonia 31 (25)
Lung cancer 11 (8.9)
Others 1 (.8)
SD, standard deviation.
a Hypertension, ischemic heart disease, cerebrovascular acc(n= 2) of young patients were misdiagnosed as lung cancer
(p= 0.01).
As regards clinical and radiological criteria of the patients
(Table 2), cough and sputum production were more common
in young than in the elderly group (p= 0.008). Dyspnea was
signiﬁcantly frequent in the elderly (p= 0.001). Non speciﬁc
general symptoms like anorexia, weight loss, weakness and
mental changes were signiﬁcantly frequent in the elderly pa-
tients (p= 0.004, <0.0001, <0.0001, 0.002, respectively).
Hemoptysis was signiﬁcantly frequent in the young
(p= 0.01). Febrile sense, night sweat and elevated body tem-
perature were signiﬁcantly frequent in young patients
(p= 0.0006, 0.002, 0.04, respectively). There was a signiﬁcant
delay in the diagnosis of pulmonary TB in the elderly group.
The mean diagnosis time was 6.2 ± 2.3 weeks in elderly com-
pared to 4.3 ± 2.1 weeks in the young group (p< 0.0001).
Radiological evaluation showed that, upper lobe involve-
ment was more common in the young group. It was 87.9%
and 70.2% for elderly and young groups respectively but iso-
late mid or lower lobe involvement was more common in the
elderly group it was 29.8% for elderly compared to 12.1%
for young. The lobar predilection was signiﬁcant
(p= 0.0006). Typical ﬁbrous nodular type with or without a
cavity lesion was signiﬁcantly more frequent in the young than
elderly patients (p< 0.0001), whereas consolidation or large
opacity mimic a mass was signiﬁcantly more frequent in the el-
derly than in young patients. P values were 0.001, 0.01,
respectively.
As regards the laboratory ﬁndings of the patients (Table 3),
positive sputum direct smear for AFB was the most common
method of pulmonary TB diagnosis in the both groups, but
signiﬁcantly more frequent in young than elderly patients
(p= 0.04). Positive sputum culture was signiﬁcantly frequent
in elderly patients (p= 0.02). Fiberoptic bronchoscope had a
higher role in the diagnosis of pulmonary TB in elderly than
young patients (16.2% elderly vs. 3.9% young patients,tial diagnosis of active pulmonary TB in elderly and
24) Young (<50 year, %) (n= 124) P value
31.6 ± 10.8 <0.0001
16–49
72 (58.1) 0.2
52 (41.9) 0.4
25 (20.2) 0.4
10 (8.1) 0.02
7 (5.6) 0.04
5 (4) 0.0008
2 (1.6) 0.7
1 (0.8) 0.9
37 (29.8) <0.0001
107 (86.3) <0.0001
15 (12.1) 0.008
2 (1.6) 0.01
0 (0) 0.3
ident were included.
Table 2 Clinical and radiological ﬁndings of active pulmonary TB in elderly and young patients.
Elderly (P50 year, %)
(n= 124)
Young (<50 year, %)
(n= 124)
P value
Clinical manifestations
Cough and sputum production 101 (81.5) 115 (92.7) 0.008
Hemoptysis 20 (16.1) 36 (29) 0.01
Dyspnea 43 (34.7) 21 (16.9) 0.001
Chest pain 14 (11.3) 9 (7.3) 0.3
Febrile sense 51 (41.1) 78 (62.9) 0.0006
Night sweat 46 (37.1) 70 (56.5) 0.002
Weakness 61 (49.2) 27 (21.8) <0.0001
Weight loss 57 (46) 25 (20.2) <0.0001
Anorexia 79 (63.7) 57 (46) 0.004
Mental changes 12 (9.7) 1 (.8) 0.002
›Body temperature 69 (55.6) 85 (68.5) 0.04
Symptom duration (mean ± SD) 6.2 ± 2.3 4.3 ± 2.1 <0.0001
(range, weeks) 4–12 3–10
Radiological ﬁnding
Location of the lesion
Upper* 87 (70.2) 109 (87.9) 0.0006
Lower¥ 37 (29.8) 15 (12.1)
Appearance of the lesion
Typical feature· 81 (65.3) 110 (88.7) <0.0001
Consolidation 28 (22.6) 10 (8.1) 0.001
Large opacity-Mass like 14 (11.3) 4 (3.2) 0.01
Others 1(.8) 0 (0) 0.3
›: elevation; *: lesion on the upper lobe only or upper lobe plus other lobe; ¥: lesion in isolated middle and/or lower
lobe; ·: ﬁbrous nodular and/or cavitary.
Table 3 Laboratory ﬁndings of active pulmonary TB in the elderly and young patients.
Elderly (P50 year, %)
(n= 124)
Young (<50 year, %)
(n= 124)
P value
Sputum
Direct smear for AFB 77 (62.1) 92 (74.2) 0.04
Culture for TB 17 (13.7) 6 (4.8) 0.02
Bronchoscope (total) 20(16.2) 5 (3.9) 0.001
Bronchoalveolar lavage (BAL)· 11 (8.9) 3 (2.3) 0.03
Histopathology¥ 9 (7.3) 2 (1.6) 0.03
Diagnosis on radiological and clinical feature only1 10 (8) 21 (17) 0.04
Hematologic ﬁndings
Leukocytic count(mean ± SD) 7 ± 3.2 7.7 ± 3.1 0.08
range · 109/L) 3–14.2 3.2–14.4
Leukocytosis (>11 · 109/L) 20 (16.1) 23 (18.5) 0.6
ESR (mean ± SD)* 91 ± 12 86 ± 19 0.01
(range, mm/hr) 65–130 60–125
: ﬁberoptic bronchoscope ;·: smear for AFB, culture for TB; ¥: for bronchoscopic biopsy; *:erythrocytic sedi-
mentation rate; 1: in absence of bacteriological or histopathological conﬁrmation for TB.
272 M.T. Hussein et al.p= 0.001). Direct smear of bronchoalveolar lavage or culture
for AFB and histopathology for ﬁberoptic bronchoscope
biopsy for TB were signiﬁcantly more frequent in elderly than
in young patients (p= 0.03, 0.03). Diagnosis of pulmonary TB
on clinical and radiological ﬁndings without bacteriological or
histopathological conﬁrmation was signiﬁcantly higher in
young patients (p= 0.04). ESR level was signiﬁcantly higher
in elderly than in young patients (p= .01).Table 4 showed details of anti-TB drug adverse reactions,
the total number of patients who experienced adverse drug
reactions was signiﬁcantly higher in elderly than in young pa-
tients (41.1% elderly vs. 17.7% young, p< 0.0001). In the el-
derly group, the mortalities related to TB were higher in elderly
than in the young group (7 elderly patients (5.6%) deceased be-
cause of TB vs. single young patient (0.03%)). The difference
in both groups was statistically signiﬁcant (p= 0.03).
Table 4 Adverse anti-TB drug reactions and treatment result of active pulmonary TB in elderly and
young patients.
Elderly (P50 year, %)
(n= 124)
Young (<50 year, %)
(n= 124)
P value
Adverse drug reaction
Mild GIT trouble 26 (21) 14 (11.3) 0.04
Severe GIT trouble 10 (8.1) 2 (1.6) 0.02
Mild liver enzyme raise 18 (14.5) 8 (6.5) 0.04
Hepatitis 7 (5.6) 1 (0.8) 0.03
Total 51 (41.1) 22 (17.7) <0.0001
Treatment result
Completed treatment 110 (88.8) 122 (98.4)
Death 14 (11.2) 2 (1.6) <0.002
TB related death 7 (5.6) 1 (.8) 0.03
Other disease 7 (5.6) 1(.8) 0.03
GIT, gastrointestinal.
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Co-morbid diseases, malnutrition and the biological changes
that are associated with aging can disrupt protective barriers,
impair microbial clearance mechanisms, and contribute to
the expected age-related decrease in cellular immune responses
to microbes such as M. tuberculosis. These factors may lead to
delay in the healing process and increase morbidity and mor-
tality in elderly TB patients [4,6].
In our study we deﬁned elderly by the age >50 years and
this is consistent with Nirmal Chand et al. (2007) who studied
TB in elderly and treatment outcome [1]. The male predomi-
nance among both elderly and young patients could be ex-
plained by their higher social and labor activities than
females, thus favoring the transmission of TB. This result
was consistently described by most of the studies [4,6–8].
The higher frequency of chronic lung, cardiovascular dis-
eases in elderly patients was not supersizing because these dis-
eases increase with aging. This result was consistent with the
results of other studies [8,12–15]. The higher frequency of liver
diseases in elderly group can be explained by the high preva-
lence of hepatitis C infection and liver cirrhosis probably due
to use of non disposable syringe in treatment of prevalent
schistosomiasis in Egypt early in the twentieth century [16–
18]. Diabetes mellitus was the most common co-morbid dis-
ease in both groups which was explained by its immunosup-
pressive effect and increased susceptibility to TB infection.
These results agreed with those of other investigators
[7,11,14]. Malignancy was not frequent co-morbid disease in
elderly patients in our study, in contrast to other studies which
recorded that malignancy was a frequent co-morbid disease in
elderly TB patients [11,14]. This could be explained by the low-
er cutting edge of elderly at 50 years compared to 60/65 years
for these studies.
Febrile sense and elevated body temperature were less fre-
quently recorded in elderly patients than in young. This can
be explained by the decreased pyrogenic response with aging
and reduced perception of fever in elderly. The lower fre-
quency of sweating in older patients is likely related to the low-
er frequency of fever in them. The elderly TB patients
commonly presented with non speciﬁc general symptoms suchas anorexia, weight loss, weakness and mental changes because
many elderly patients visit physicians after the disease had pro-
gressed to advanced stage due to lower awareness of the dis-
ease among them, and poor socioeconomic status in our
society. These results were in agreement with those of other
studies [1,7,12,19]. Although cough and sputum production
were common symptoms in both young and elderly patients,
they were statistically signiﬁcant in young patients. This result
was in agreement with other authors [7,11,19,20]. In our study,
the higher frequency of hemoptysis in young patients was
probably related to the higher frequency of lung cavitations
in them. This was in agreement with other authors [4,8]. Kor-
zeniewska-Kosela et al. (1994), Umeki (1989), and Lee et al.
(2005) recorded that, no difference between elderly and young
patients as regards cough, sputum production and hemoptysis,
inconsistent with our study which recorded higher frequency of
presentation of elderly by non speciﬁc manifestations which
could be explained by earlier pulmonary TB detection by mass
survey in the former studies [21,22,11].
The higher frequency of dyspnea in elderly patients can be
explained by the decrease in pulmonary function with aging,
higher frequency of chronic lung and cardiovascular diseases
in elderly. These results was consistent with other studies
[4,7,23]. The delayed diagnosis of pulmonary TB in elderly
may be due to the higher frequency of unusual clinical presen-
tation (which may be confused with age-related illness) and X-
ray image showing atypical radiological presentation and/or to
the lower awareness of the disease among them. This result
was in agreement with many authors [1,4,8,11,15]. While, Pe´r-
ez-Guzma´n et al. (1999) recorded that no difference between
elderly and young patients in duration of diagnosis which
could be explained by earlier pulmonary TB detection by mass
survey in this study [13].
In our study atypical radiological presentation of pulmon-
ary TB in elderly led to misdiagnosis as pneumonia or lung
cancer initially and this consistent with the results of Nirmal
Chand et al. (2007), Mori and Leung (2010) who recorded in-
crease frequency of TB lower lobe involvement with age and
the frequency of cavitations steadily decrease with age [1,4].
Only selected patients received a ﬁberoptic bronchoscope
examination, BAL, brush and/or biopsy. This role was more
274 M.T. Hussein et al.prominent among elderly due to higher un-ability to expecto-
rate sputum, atypical clinical and radiological ﬁndings and ini-
tial misdiagnosis as lung cancer. This was in agreement with
different studies [4,5,11,24,25]. Higher frequency of diagnosis
of pulmonary TB on clinical and radiological picture (in ab-
sence of bacteriological or histopathological conﬁrmation) in
young than elderly patients could be explained by the higher
atypical clinical and radiological presentation of pulmonary
TB in elderly. This was in agreement with other authors [1,6,8].
In our study, ESR level of elderly TB patients was signiﬁ-
cantly higher than that of young patients and this is probably
due to normal increase of ESR with age [3,26]. This was in
agreement with Lee et al. 2005 [11]. No signiﬁcant difference
in leukocytic count was observed between elderly and young
patients, in our study. This result was in agreement with other
authors [1,11] while, Cruz-Hervert et al. (2012) recorded that
elderly patients had a lower leukocytic count which could be
explained by the age related immunosuppression (the lower
cutting edge of elderly at 65 years for this study compared to
50 years for our study) [6].
The higher frequency of anti-TB drugs adverse reactions in
elderly was in agreement with different Egyptian and world-
wide studies [6,10,15,27,28]. It is not surprising the TB related
mortality was higher in elderly than young patients and this
could be explained by age-related immunosuppression, malnu-
trition, co-morbid diseases, delayed diagnosis and initiation of
treatment in them. This was in agreement with different
authors [1,4,6–8,15].
Recommendation
A high index of suspicion and prompt investigations in elderly
patients are mandatory for early diagnosis and treatment of
TB hoping for decreasing TB related morbidity and mortality.
Careful monitoring of elderly patients for adverse effects of
anti-TB drugs is indicated.References
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